Sign in

CIK 0001721484

  • Emerging growth company

Longeveron Inc.

Sign in to watch
Ticker
LGVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472174146
Phone
+1 305-302-7158
Business address
1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
Former names
LONGEVERON LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 14 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-10-07 Clavijo James CFO and Treasurer Purchase +5,000 $3.34 $17K 79,598
2021-10-07 Lehr Paul T General Counsel, Secretary Purchase +1,750 $3.34 $6K 116,366
2021-10-07 Hare Joshua Chief Scientific Officer Purchase +1,985 $3.38 $7K 7,927,748
2021-10-01 Lehr Paul T General Counsel, Secretary Shares withheld for taxes −38,752 $3.65 $141K 114,616
2021-10-01 Clavijo James CFO and Treasurer Shares withheld for taxes −19,052 $3.65 $70K 74,598
2021-10-01 Green Geoff CEO Shares withheld for taxes −43,929 $3.65 $160K 138,723
2021-07-20 Hare Joshua Chief Scientific Officer Grant or award +12,335 7,925,763
2021-07-20 Hare Joshua Chief Scientific Officer Grant or award · Stock Option (right to buy) +50,000 50,000
2021-07-20 Clavijo James CFO and Treasurer Grant or award · Stock Option (right to buy) +50,000 50,000
2021-07-20 Green Geoff CEO Grant or award +8,223 182,652
2021-07-20 Green Geoff CEO Grant or award · Stock Option (right to buy) +75,000 75,000

Page 14 of 14 · 271 trades